Israel - English - Ministry of Health

eldan electronic instruments co ltd, israel - dextrose anhydrous; sodium chloride - solution for infusion - dextrose anhydrous 4.3 %w/v; sodium chloride 0.18 %w/v - sodium chloride - dextrose 4.3 % and 0.18 % sodium chloride vioser solution is used in the following indications: dehydration treatment due to a moderated loss of sodium and chloride (vomiting, diarrhoea, renal disorders, over use ofdiuretics) in cases where a source of energy is required (particularly starvation). paediatric population: this product should only be used in paediatric specialist settings (such as renal, hepatic and cardiac units, high dependency units and intensive care units) for intravenous fluid therapy requiring the use of 0.18% sodium chloride and4% glucose to maintain fluid and electrolyte balance.

United States - English - NLM (National Library of Medicine)

hospira, inc. - dextrose, unspecified form (unii: iy9xdz35w2) (dextrose, unspecified form - unii:iy9xdz35w2), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium acetate anhydrous (unii: nvg71zz7p0) (sodium cation - unii:lyr4m0nh37), sodium gluconate (unii: r6q3791s76) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838) - dextrose 5 g in 100 ml - normosol-r and 5% dextrose injection is indicated for replacement of acute extracellular fluid volume losses in surgery, trauma, burns or shock. normosol-r and 5% dextrose also can be used as an adjunct to restore a decrease in circulatory volume in patients with moderate blood loss. the solution is not intended to supplant transfusion of whole blood or packed red cells in the presence of uncontrolled hemorrhage or severe reductions of red cell volume. none known.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

b.braun pharmaceuticals epz ltd, kenya - dextrose , sodium chloride - solution for injection - sodium chloride 0.9gms and glucose 5gms

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient. none known.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient. none known. check flexible container solution composition, lot number, and expiry date. do not remove solution container from its overwrap until immediately before use. use sterile equipment and aseptic technique. to open - turn solution container over so that the text is face down. using the pre-cut corner tabs, peel open the overwrap and remove solution container. - check the solution container for leaks by squeezing firmly. if leaks are found, or if the seal is not intact, discard the solution. - do not use if the solution is cloudy or a precipitate is present. to add medication - identify white additive port with arrow pointing toward container. - immediately before injecting additives, break off white additive port cap with the arrow pointing toward container. - hold base of white additi

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient. none known. check flexible container solution composition, lot number, and expiry date. do not remove solution container from its overwrap until immediately before use. use sterile equipment and aseptic technique. to open - turn solution container over so that the text is face down. using the pre-cut corner tabs, peel open the overwrap and remove solution container. - check the solution container for leaks by squeezing firmly. if leaks are found, or if the seal is not intact, discard the solution. - do not use if the solution is cloudy or a precipitate is present. to add medication - identify white additive port with arrow pointing toward container. - immediately before injecting additives, break off white additive port cap with the arrow pointing toward container. - hold base of white additiv

Singapore - English - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - dextrose hydrous; potassium chloride; sodium chloride - injection - 50 g/l - dextrose hydrous 50 g/l; potassium chloride 1.5 g/l; sodium chloride 3.3 g/l

Canada - English - Health Canada

baxter corporation - dextrose; sodium chloride; potassium chloride - solution - 5g; 450mg; 150mg - dextrose 5g; sodium chloride 450mg; potassium chloride 150mg - replacement preparations

Canada - English - Health Canada

baxter corporation - dextrose; sodium chloride; potassium chloride - solution - 5g; 450mg; 300mg - dextrose 5g; sodium chloride 450mg; potassium chloride 300mg - replacement preparations

Canada - English - Health Canada

baxter corporation - dextrose; sodium chloride; potassium chloride - solution - 5g; 900mg; 150mg - dextrose 5g; sodium chloride 900mg; potassium chloride 150mg - replacement preparations